本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

43.00
-0.5900-1.35%
盘后43.000.00000.00%16:08 EDT
成交量:133.24万
成交额:5,739.49万
市值:68.44亿
市盈率:-14.35
高:43.66
开:43.35
低:42.44
收:43.59
数据加载中...
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report